Dr Frank Thielmann

Categories: ATMPs Focus Group
Dr Frank Thielmann is a Material Scientist by training. He joined the Novartis Biologics Manufacturing department as the Lead for PMO & Operational Excellence in 2016. In July 2018 he took on additional responsibility for new the Novartis European manufacturing site for Cell & Gene Therapeutics in Switzerland before moving to Takeda end of 2019. At Takeda Frank is responsible as Operational Excellence Director for the implementation of process improvement in the manufacturing of a wide portfolio ranging from small molecules to ATMPs.
Go to Top